Aging puzzle: A closer look on the complex dilemma of autologous stem cell therapy

Table 4 Comparison of emerging strategies to augment regenerative potential of stem cells in the elderly

Strategy	Efficacy	Practicality	Cost-effectiveness	Major bottlenecks
HPC	Effective for rejuvenating stem cells by mimicking natural hypoxic environments, improving mitochondrial efficiency and reducing ROS accumulation	Relatively simple to implement in vitro but translating to in vivo conditions is challenging due to varying oxygen tensions	Low cost for in vitro applications; however, in vivo translation may incur higher costs	Difficulty in replicating in vivo oxygen conditions; risk of increasing genomic instability or harmful factor secretion in aged cells
Genetic modification (CRISPR/Cas9)	Highly effective in precisely editing genes associated with aging and cellular senescence, improving stem cell function	Technically challenging; requires specialized expertise and equipment	High initial cost for setup, but cost-effective for large-scale genetic modifications	Off-target effects; potential risk of inducing tumorigenesis or mutations in aged stem cells
Growth factor supplementation	Effective for enhancing cell survival, proliferation, and differentiation, especially in aged cells	Easy to apply, but requires careful management of dosages and delivery systems	Moderate to high cost depending on the growth factor and delivery system used	Short half-life of growth factors limits their long-term effectiveness; managing consistent delivery in vivo is challenging
Bioactive compounds	Promising for enhancing stem cell function through modulation of pathways like oxidative stress and mitochondrial function	Non-invasive and easy to implement, but requires high doses for efficacy	Relatively low cost for sourcing and application, though clinical use may require further investment	High doses required for efficacy, potentially leading to toxicity in elderly patients
Hybrid stem cell therapy	Effective for combining the strengths of different stem cell types (e.g., iPSCs for differentiation and MSCs for paracrine support)	Complex to implement and requires co-transplantation of different stem cell types or integration with biomaterials	High cost due to the need for multiple stem cell types and specialized biomaterials	Ensuring the stability and functionality of hybrid stem cell constructs; maintaining consistent results across heterogeneous cell populations
MSC-derived exosomes	Promising in promoting tissue repair and anti-inflammatory responses without the need for live-cell transplantation	Easy to apply in comparison to cell transplantation, but large-scale production and purification can be challenging	Moderate cost, but cell-free nature could reduce long-term treatment costs	Production scalability; ensuring exosome consistency across populations; unknown long-term effects
Activation of developmental signaling pathways	Effective for rejuvenating stem cells and restoring their regenerative potential by reactivating pathways like Wnt, Notch, Hedgehog, and PI3K/Akt	Technically feasible but requires precise control over pathway activation to avoid undesired effects like tumorigenesis	High cost due to the need for specialized reagents and tools for pathway modulation	Excessive or uncontrolled activation of pathways could lead to unwanted effects such as tumorigenesis; requires precise control
3D culture systems	Effective for improving stem cell behavior by providing a more physiologically relevant environment than traditional 2D cultures	Complex and requires specialized equipment and expertise	High initial cost for 3D culture systems, but cost-effective in the long term for large-scale research	Difficulty in translating results from 3D culture systems to in vivo applications; complexity of culture systems
Epigenetic rejuvenation	Effective for resetting the epigenetic clock and restoring stem cell function, particularly through small molecules and histone modifications	Relatively easy to implement, though the long-term effects of epigenetic modulation are not fully understood	Moderate cost for small molecules and inhibitors	Risk of inducing oncogenes or pluripotency; difficulty in achieving precise epigenetic control, especially in heterogeneous cell populations

HPC: Hypoxic preconditioning; ROS: Reactive oxygen species; MSC: Mesenchymal stem cell; iPSCs: Induced pluripotent stem cells; 3D: Three-dimensional; PI3K: Phosphatidylinositol 3-kinase; Akt: Protein kinase B.